Japan Considers Increasing Production Of Avian Flu Vaccine
This article was originally published in PharmAsia News
Japan's Ministry of Health, Labor and Welfare is considering increasing production of avian flu vaccine, adding to the current stockpile of 10 million doses. In preparing for the possibility of an avian flu epidemic, with vaccine production taking six months, the government plans to produce the pandemic vaccine based on the highly mutable H5N1 type virus, to be used by medical workers immediately following an epidemic outbreak. A more effective vaccine can be produced later on for the general population. (Click here for more-Japanese language
You may also be interested in...
The company said its own calculations suggest a mid-November readout could yield a positive result, keeping it on track for an EUA before the end of 2020.
With COVID-19 continuing to wreak havoc in the EU just as throughout the globe, the European Commission is proposing new measures that will impact antigen test availability and use
Amgen’s management took a deep dive into biosimilar market dynamics during the company’s third-quarter earnings call, as the California-based biotech continued to enjoy success for biosimilars in the US and Europe.